BELITE BIO INC - ADR (BLTE) Stock News

USA - NASDAQ:BLTE - US07782B1044 - ADR

79.28 USD

+0.78 (+0.99%)

Last: 10/10/2025, 9:12:44 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BLTE Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Belite Bio, Inc

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

a month ago - By: Belite Bio, Inc

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

a month ago - By: Belite Bio, Inc

Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors

2 months ago - By: Benzinga

Belite Bio's Earnings Outlook

a month ago - By: Belite Bio, Inc

Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors

a month ago - By: Belite Bio, Inc

Belite Bio to Participate in Three Upcoming Investor Conferences

2 months ago - By: Belite Bio, Inc

Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

2 months ago - By: Belite Bio, Inc

Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

5 months ago - By: Benzinga

Earnings Outlook For Belite Bio

2 months ago - By: Belite Bio, Inc

Belite Bio Announces Registered Direct Offering of $15 Million

2 months ago - By: Belite Bio, Inc

Belite Bio Announces Registered Direct Offering of $15 Million

2 months ago - By: Belite Bio, Inc

Belite Bio to Participate in the H.C. Wainwright Annual Ophthalmology Virtual Conference

2 months ago - By: Belite Bio, Inc

Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results

3 months ago - By: Belite Bio, Inc

Belite Bio to Participate in the BTIG Virtual Biotechnology Conference

3 months ago - By: Belite Bio, Inc

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

3 months ago - By: Belite Bio, Inc

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

5 months ago - By: Belite Bio, Inc

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease

5 months ago - By: Belite Bio, Inc

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease

5 months ago - By: Virtual Investor Conferences - Mentions: VIOT LSE - HCM ...

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

5 months ago - By: Belite Bio, Inc

Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

5 months ago - By: Belite Bio, Inc

Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

5 months ago - By: Virtual Investor Conferences

Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th

5 months ago - By: Belite Bio, Inc

Belite Bio to Participate in Four Upcoming Investor Conferences

5 months ago - By: Belite Bio, Inc

Belite Bio to Participate in Four Upcoming Investor Conferences

5 months ago - By: Virtual Investor Conferences - Mentions: YRD IH VIOT LSE ...

UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

5 months ago - By: Virtual Investor Conferences - Mentions: YRD IH VIOT LSE ...

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

5 months ago - By: Belite Bio, Inc

Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results

5 months ago - By: Belite Bio, Inc

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting

5 months ago - By: Belite Bio, Inc

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting

7 months ago - By: Belite Bio, Inc

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

7 months ago - By: Belite Bio, Inc

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

7 months ago - By: Belite Bio, Inc

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

7 months ago - By: Belite Bio, Inc

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update